220 related articles for article (PubMed ID: 25223735)
21. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
24. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
Hou Y; Li H; Huo W
Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
[TBL] [Abstract][Full Text] [Related]
25. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
[TBL] [Abstract][Full Text] [Related]
26. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
Taghizadeh R; Noh M; Huh YH; Ciusani E; Sigalotti L; Maio M; Arosio B; Nicotra MR; Natali P; Sherley JL; La Porta CA
PLoS One; 2010 Dec; 5(12):e15183. PubMed ID: 21203549
[TBL] [Abstract][Full Text] [Related]
27. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.
He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A
Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558
[TBL] [Abstract][Full Text] [Related]
28. PI3K/Akt inhibitor partly decreases TNF-α-induced activation of fibroblast-like synoviocytes in osteoarthritis.
Liu S; Cao C; Zhang Y; Liu G; Ren W; Ye Y; Sun T
J Orthop Surg Res; 2019 Dec; 14(1):425. PubMed ID: 31829201
[TBL] [Abstract][Full Text] [Related]
29. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
32. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
[TBL] [Abstract][Full Text] [Related]
33. Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells.
Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L
Curr Med Chem; 2011; 18(18):2715-26. PubMed ID: 21649579
[TBL] [Abstract][Full Text] [Related]
34. Honokiol inhibits melanoma stem cells by targeting notch signaling.
Kaushik G; Venugopal A; Ramamoorthy P; Standing D; Subramaniam D; Umar S; Jensen RA; Anant S; Mammen JM
Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
[TBL] [Abstract][Full Text] [Related]
35. STAT3-induced ZBED3-AS1 promotes the malignant phenotypes of melanoma cells by activating PI3K/AKT signaling pathway.
Wang Y; Lou N; Zuo M; Zhu F; He Y; Cheng Z; Wang X
RNA Biol; 2021 Oct; 18(sup1):355-368. PubMed ID: 34241580
[TBL] [Abstract][Full Text] [Related]
36. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway.
Xiao M; Men LN; Xu MG; Wang GB; Lv HT; Liu C
Eur J Pharmacol; 2014 Nov; 743():11-6. PubMed ID: 25257463
[TBL] [Abstract][Full Text] [Related]
37. The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway.
Li P; Gan Y; Xu Y; Song L; Wang L; Ouyang B; Zhang C; Zhou Q
Sci Rep; 2017 Feb; 7():42938. PubMed ID: 28211497
[TBL] [Abstract][Full Text] [Related]
38. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
Kumar SM; Yu H; Fong D; Acs G; Xu X
Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
[TBL] [Abstract][Full Text] [Related]
40. PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes.
Larribere L; Khaled M; Tartare-Deckert S; Busca R; Luciano F; Bille K; Valony G; Eychene A; Auberger P; Ortonne JP; Ballotti R; Bertolotto C
Cell Death Differ; 2004 Oct; 11(10):1084-91. PubMed ID: 15243584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
